Displaying items by tag: department of pathology

To facilitate gene-level queries of data from more than 10,000 cancer patient transcriptome sequences and proteomics data from 2,000 patients, researchers have developed a user-friendly cancer data analysis web platform called UALCAN.
For just the third time in history, a University of Alabama at Birmingham faculty member has been elected to the prestigious National Academy of Sciences.
Researchers show how two types of immune cells — one a part of the innate immune system and the other a part of the adaptive immune system — play distinct and indispensable roles in the colon to defend against pathogenic bacteria.
Join UAB’s O’Neal Comprehensive Cancer Center to learn about the rare blood cancer multiple myeloma.
The grant will fund research surrounding next-generation human models that could potentially aid in the development of treatment for glioblastoma.
In response to a viral infection, intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling, leading to different fates for two subsets of those cells — the one producing IL-2 and the one not producing IL-2.
The human preclinical model at UAB provides important knowledge before a Phase I clinical trial can begin for living human recipients. Decades of work by researchers across the world preceded UAB’s first clinical-grade pig kidney xenotransplant.

UAB O’Neal Comprehensive Cancer Center, Morehouse School of Medicine and Tuskegee University collectively receive $18 million U54 grant from the National Cancer Institute.

After years of researching the SON gene, Erin Eun-Young Ahn, Ph.D., may have found the cause behind an extremely rare disease. 

The O’Neal Invests program funds UAB investigators starting new cancer-related projects to initiate key, preliminary work needed to enable competitive R01 applications from the NIH.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under

Yabing Chen, Ph.D., is the first researcher at the Birmingham VA to receive this highest honor for a non-physician scientist.

In this arteriolar niche, breast cancer stem cells and arteriolar endothelial cells cross-talk using a well-known signaling pathway. Targeting this pathway may offer therapeutic potential.

Sixto Leal, M.D., Ph.D., was featured in the “Front(line) and Center” category in the Pathologist's 2021 Power List recognizing some of the most inspirational pathologists and laboratory medicine professionals in the U.S. in 2021.

UAB students in the Honors College are equipping the next generation of scientists with cancer biology knowledge through hands-on experiments and interactive projects, helping to spread cancer awareness in Birmingham and surrounding communities.
Page 1 of 8